By the end of this presentation, you should be able to:
Describe basic pharmacokinetic principles of monoclonal antibodies
Understand reasons for variability in monoclonal antibody levels between patients
Appreciate the exposure-response relationship with monoclonal antibodies in rheumatoid arthritis
Understand the role and limitations of measuring drug levels and anti-drug antibodies in clinical practice
Speaker Name: 
3031 Duke South
Durham, NC 27701
United States
Session date: 
Tuesday, June 5, 2018 - 8:00am to 9:00am
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Attendance

Please login or register to take this course.